Curriculum Vitae s142

Curriculum Vitae J. Philip Miller

Date: July 15, 2009

Citizenship

Address and Telephone Numbers

Office: Division of Biostatistics Washington University School of Medicine 660 South Euclid Avenue, Campus Box 8067 St. Louis, Missouri 63110

(314) 362-3617 - Office (314) 362-3440 – Fax (314) 757-4135 – Cell

Home: 6230 Waterman St. Louis, Missouri 63130

(314) 726-5448 - Home

Email: [email protected]

Present Position

1989-Present Professor of Biostatistics, Washington University School of Medicine, St. Louis, MO

Education

1961-1965 AB, Psychology, Washington University, St. Louis, MO 1965-1968 Graduate Study, Psychology, Washington University, St. Louis, MO

Academic Positions/Employment:

1989-Present Professor of Biostatistics, Washington University School of Medicine, St. Louis, MO 1982-1989 Associate Professor, Biostatistics, Washington University School of Medicine, St. Louis, MO 1978-1982 Assistant Professor, Preventive Medicine (Biostatistics), Washington University School of Medicine, St. Louis, MO 1975-1978 Instructor, Preventive Medicine (Biostatistics), Washington University School of Medicine, St. Louis, MO 1975-1976 Instructor, Systems Science & Mathematics, Sever Institute, Washington University, St. Louis, MO

University and Hospital Appointments and Committees

2000-Present Director, Data Management and Biostatistics Core, Siteman Cancer Center, St. Louis, MO 1998-Present Director, Data Management and Biostatistics Core, Cognitive Rehabilitation Research Group, Washington University School of Medicine, St. Louis, MO 1989-Present Director, Data Management and Biostatistics Core, Healthy Aging and Senile Dementia Program Project, Washington University School of Medicine, St. Louis, MO 1988-Present Director, WUBIOS Computing Resource, Washington University School of Medicine, St. Louis, MO 1984-Present Director, Data Management and Biostatistics Core, Alzheimer's Disease Research Center, Washington University School Medicine, St. Louis, MO 1996-2000 Director, Biostatistics and Clinical Trials Core, Siteman Cancer Center, St. Louis, MO 1987-1993 Director, Biostatistics Core, Falling and Hip Fracture: Causes, Risks and Outcome Program Project, Washington University School of Medicine, St. Louis, MO 1987-1992 Director, Biostatistics Core, AIDS Clinical Trial Group, Washington University School of Medicine,St. Louis, MO 1975-1988 Director, Patient Registry, Diabetes and Endocrinology Center, Washington University School of Medicine, St. Louis, MO 1973-1975 Statistical Consultant, Division of Child Psychiatry, Washington University School of Medicine, St. Louis, MO 1972-1974 Data Manager, Lipid Research Center, Washington University School of Medicine, St. Louis, MO 1972-1981 Statistical Analyst, Relationship of Ventricular Arrhythmias to Sudden Death in Survivors of Myocardial Infarction Project, Washington University School of Medicine, St. Louis, MO

Professional Societies and Organizations

American Statistical Association Biometric Society Society for Clinical Trials Society for Epidemiological Research

Consulting Relationships and Board Memberships

Member Data and Safety Monitoring Boards for a number of NIH and industry-sponsored clinical trials Grant Application Reviewer NIH (various ad hoc groups, especially for NIA, NHLBI, NIAMS, National Cancer Institute), Veterans Administration, Muscular Dystrophy Association Permanent Member Geriatrics and Rehabilitative Medicine Study Section (Genisis -2001)

Research Support (current)

Governmental

Core Director Alzheimer's Disease Research Center – Biostatistics Core 04/1/1995-03/31/2010 $74,771.00

Core Director Health Aging and Senile Dementia 01/01/1999-12/31/2008 $85,640.00

Co-Investigator Neuromorphometry in Schizophrenia by Computer Algorithm 08/01/1999-04/30/2007 $271,634.00

Co-Investigator Very Early Constraint Induced Movement Therapy for Stroke 12/01/2001-11/30/2006 $313,430.00

Principal Investigator Data Coordinating Center for PKD Treatment Network (HALT PKD) 08/01/2002-01-31-2010 $320,187.00

Co-Investigator Extreme Longevity Family Study – DMCC 08/15/2004-07/31/2009 $533,964.00

Core Directorr Cancer Center Support Grant 08/02/2001-06/30/2009 $899,209.00

Co-Investigator Washington University Molecular Imaging Center 05/31/2002-03/31/2007 $1,227,101.00 2 Co-Investigator Ocular Hypertension Treatment Study (OHTS) – Data Coordinating Center 12/01/1997-11/30/2008 $924,980.00

Co-Investigator Data Coordinating and Imaging Analysis Center for Polycystic Kidney Disease (CRISP) (PI: Ty Bae) 12/01/2000-11/30/2010

NonGovernmental

Principal Investigator Collaborative Investigations for Duchenne Dystrophy – Data Coordinating Center 1978-Present Muscular Dystrophy Association

Research Support (recent past)

Governmental

Subcontract PI The Extremity Constraint-Induced Therapy Evaluation (EXCITE) – Data Management Center, 03/31/2000-03/31/2005 Principal Investigator Frailty and Injuries: Cooperative Studies of Intervention Techniques (FICSIT) Coordinating Center, 1990-1996 Co-Investigator Linking Peer and Neighborhood Based Smoking Cessation with Clinic Based Services for Low Income African Americans (PI: Edwin Fisher) Co-Investigator Predictors of Relapse to Smoking in Lung Cancer (PI: Edwin Fisher) Co-Investigator Imaging Multi-Drug Resistance and Modulation in Breast Cancer (PI: David Piwnica-Worms) Co-Investigator Physical Frailty in Urban African-Americans (PI: Douglas K. Miller) Co-Investigator Improving Cognitive Performance: Linking Biology, Environment, and Behavior (PI: Carolyn Baum) Co-Principal Investigator 15 Year Follow-up of 5500 black and 5500 Other Hyptertensives (PI: H. Mitchell Perry)

Teaching Title and Responsibilities

1971-1972 Manager, User Services, Computing Facilities, Washington University, St. Louis, MO 1969-1972 Manager, Documentation, Computing Facilities, Washington University, St. Louis, MO 1967-1969 Staff Specialist for Social Sciences, Computing Facilities, Washington University, St. Louis, MO 1967-1977 Instructor, Systems and Data Processing, University College, Washington University, St. Louis, MO 1965-1966 Research Assistant, Department of Psychology, Washington University, St. Louis, MO 1964-1967 Research Assistant, Biomedical Computer Laboratory, Washington University, St. Louis, MO

Bibliography

Peer-Reviewed Publications

1. Miller JP, Psathas G. A 1401-1311 General Inquirer Tagging Program. Behavioral Science 1968: 13:167- 169. 2. Miller JP, Bohn SE, Gilden JP, Stevens E. Anxiety as a Function of Taking the MMPI. J Consult & Clin Psych 1968: 32:120-124. 3. Miller JP, Arp DJ, Psathas G. An Introduction to the Inquirer II System of Content Analysis. Comp Studies in Humanities & Verbal Behavior III 1970: 40-45. 4. Oliver GC, Kleiger RE, Krone RJ, Martin TF, Miller JP, Nolle FM, Cox JR, Jr. Application of the High Speed Analysis of Ambulatory Electrocardiograms. Proceedings of Computers in Cardiology 1974: 43-46. 5. Schonfeld G, Birge C, Miller JP, Kessler G, Santiago J. Apolipoprotein B Levels and Altered Lipoprotein Composition in Diabetes. Diabetes 1974: 23:827-834. 6. Oliver GC, Miller JP, Martin TF. A Critical Review of Computer ECG Monitoring: Present Confusion and Future Promise. In Computer Electrocardiography and Vectocardiography: Current Status, Futura Press 1974.

3 7. Achtenberg J, Miller JP. Diabetes Center Patient Registry. Proc 1975 MUMPS Users Group, J Zimmerman (ed), MUMPS Users' Group, St. Louis, 1975: 1-7. 8. Kleiger RE, Martin TF, Miller JP, Oliver GC. Mortality of Myocardial Infarction Treated in the CCU. Heart & Lung 1975: 4:215-226. 9. Hillman L, Schonfeld G, Miller JP, Wulff G. Apolipoproteins in Human Pregnancy. Metabolism 1975: 24:943- 952. 10. Miller JP. The Relationship of SAS to Other Packages. Proceedings of the 1976 SAS Users Group, J Horwitch (ed) SAS Institute, Raleigh NC, 1976: 380-387. 11. Miller JP, Ritter JA, Clark KW, Thomas LJ, Jr, Oliver GC. Extended Analysis of Argus/H Quantified Ventricular Ectopic Activity. Proceedings of Computers in Cardiology, IEEE Cat No 76-CH-1160-1C, 1976: 165-170. 12. Moore P, Miller JP, Moran M, Clark KW, Oliver GC. A Management Information System Designed to Oversee a Clinical Study. Proceedings of 1976 MUMPS Users Group, J Rothmier (ed), St. Louis, Missouri, 1976: 85-96. 13. Achtenberg JA, Miller JP, Cryer P, Santiago J. Data 3 - A Forms Management System. Proc 1976 MUMPS Users Group, J Rothmeier, (ed), St. Louis, Missouri, 1976: 1-8. 14. Miller JP. A Parsimonious Approach to Data Transformations. Proceedings of the 2nd Annual SUGI, SAS Institute, K Offord (ed), Raleigh, NC, 1977: 74-78. 15. Clark KW, Moore P, Miller JP, Thomas LJ, Jr. A Total Systems Approach to the Quantitative Analysis of Holter-Recorded ECGs. Proc Int Symposium on Ambulatory Monitoring, Academic Press, 1977: 59-71. 16. Miller JP, Moore P, Achtenberg J, Thomas LJ, Jr. Computerized Information Handling for Long-Term Clinical Studies. Proceedings of the 1977 Computers in Cardiology, IEEE Catalog 77-CH-1243-2C, 1977:151- 159. 17. Oliver GC, Ripley KL, Miller JP, Martin TF. A Critical Review of Computer Arrhythmia Detection. Computer Electrocardiography: Present Status and Criteria. L Pordy (ed), Futura Press, 1977: 319-326. 18. Miller JP. Discussion for Invited Session on Research Data Management. Proceedings of the 1977 Statistical Computing Section, Am Stat Assoc, 1977: 73-75. 19. Miller JP. A Parsimonious Approach to Data Transformations. Proceedings of the 1977 Statistical Computing Section, Am Stat Assoc, 1977: 327-331. 20. Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD, Jr. Chronic Progressive Renal Disease: Rate of Change of Serum Creatine Concentration. Kidney Inter II 1977: 62-70. 21. Burslem J, Schonfeld G, Howald MA, Weidman SW, Miller JP. Plasma Apoprotein and Lipoprotein Lipid Levels in Vegetarians. Metabolism 1978: 27:711-719. 22. Kass MA, Palmberg PK, Becker B, Miller JP. Histocompatibility Antigens and Primary Open-Angle Glaucoma - A Reassessment. Arch Ophthamology 1978: 96:2207-2208. 23. Achtenberg J, Miller JP. Interfacing a MUMPS-Based Data Entry System to SAS. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Institute, Raleigh, NC, 1978: 161-167. 24. Powell D, Miller JP, Cloninger CR. The Use of SAS for the Analysis of Family Studies. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Institute, Raleigh, NC, 1978: 189-194. 25. Miller JP, McCrate MM, Province MA, Wette R. Maximum Likelihood Estimation of the Multivariate Logistic. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Inst, Raleigh, NC, 1978: 303-305. 26. Miller JP, Spitznagel E, Jr, Kass M. The Use of Loglinear and Multivariate Logistic Models to Assess the Association Between HLA Antigen Responses and Disease. Proceedings of the Statistical Computing Section, Am Stat Assoc, 1978: 271-275. 27. Moore P, Miller JP, Oliver GC, Thomas LJ, Jr. Task-Oriented Management Information Systems for Clinical Studies. Proceedings of 1978 Computers in Cardiology, IEEE 78-CH-1391-2C, 1978: 149-154. 28. Hruska KA, Teitelbaum SL, Kopelman R, Richardson CA, Miller JP, Debman J, Martin K, Slatopolsky E. The Predictability of the Histological Features of Uremic Bone Disease by Noninvasive Techniques. Metab Bone Dis & Related Research 1978: 1:39-44. 29. Miller JP. The Role of SAS in the Support of Clinical Studies in Medicine. Proceedings of the 4th Annual Conference of SUGI, SAS Inst. Raleigh, NC, 1979: 300-305. 30. Thanavaro S, Krone RJ, Kleiger RE, Province MA, Miller JP, deMello VR, Oliver GC. In-Hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions. Int Congress Series No. 491: Florence International Meeting on Myocardial Infarction, Excerpta Medica, Princeton, 1979: 99-102. 31. Krone RJ, Igielnik S, Miller JP. A Computerized Cardiology Report Generating/Data Management System. Proceedings of the 1979 Computers in Cardiology, IEEE 79-CH1462-1, 1979: 469-472. 32. Kilo C, Williamson JR, Choi SC, Miller JP. Insulin Treatment and Diabetic Vascular Complications. (Letter) J Am Medical Assn 1979: 241:26. 33. Cloninger CR, Miller JP, Wette R, Martin RL, Guze SB. The Evaluation of Diagnostic Concordance in Follow-up Studies: I. A General Model of Casual Analysis and a Methodological Critique. J Psych Reseach 1979: 15:85-106. 4 34. Kilo C, Williamson JR, Choi SC, Miller JP. Refuting the UGDP Conclusion that Insulin Treatment Does Not Prevent Vascular Complications in Diabetes. Treatment of Early Diabetes: Advances in Experimental Medicine in Biology, RA Camerini-Davalos, B Hanover, (eds), Plenum Press, NY, 1979: 119:307-311. 35. Martin TF, Kleiger RE, Miller JP, deMello V, Oliver GC. Longterm Stability of Ventricular Arrhythmias After Recovery from Infarction. Progress in Cardio-Pulmonary Diseases, MP Anand, SJ Shah, (eds), States People Press, Bombay, India, 1979: 80-93. 36. Thanavaro S, Krone RJ, Kleiger RE, Province MA, Miller JP, deMello V, Oliver GC. In-Hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions. Circulation 1980: 61:29-33. 37. Kilo C, Miller JP, Williamson J. The Achilles Heel of the University Group Diabetes Program. J Am Medical Assn 1980: 243:450-457. 38. Clark KW, Rolnitzky LM, Miller JP, DeCamilla JJ, Kleiger RE, Thanavaro S, Bigger JT, Jr, and other MPIP Participants. Ambulatory ECG Analysis Shared by Two Independent Computer Labs in the Multicenter Post- Infarction Program (MPIP). Proceedings of the 1980 Computers in Cardiology, IEEE 80CH1606-3, 1981: 271- 274. 39. Brandenberger LL, Oliver GC, Miller JP, Thomas LJ, Jr, Moore P. Development of a Computer-Assisted Follow-up Method for Clinical Research. Proceedings of the 4th Annual Symposium on Computer Applications in Medical Care, IEEE 80CH1570-1, 1980: 1037-1043. 40. Kilo C, Miller JP, Williamson JR. The Crux of the UGDP. Spurious Results and Biologically Inappropriate Data Analysis. Diabetologia 1980: 18:179-185. 41. Kass, MA, Hart WM, Gordon M, Miller JP. Risk Factors Favoring the Development of Glaucomatous Visual Field Loss in Ocular Hypertension. Survey Ophth 1980: 25:155-162. 42. Krone JR, Igielnik S, Miller JP. A Computerized Report Generating/Data Management System for a Cardiology Division. Proceedings of the 4th Annual WAMI Meeting, FB Begon (ed), Strasbourg, France, 1981: 277-282. 43. Kleiger RE, Miller JP, Thanavaro S, Province MA, Martin TF, Oliver GC. Relationship Between Clinical Features of Acute Myocardial Infarction and Ventricular Runs 2 Weeks to 1 Year after Infarction. Circulation 1981: 63:64-70. 44. Rice JP, Miller JP, Cloninger CR. Path Analytic Models in Human Quantitative Genetics. Proceedings of the 6th Annual SUGI Conference, SAS Institute, Raleigh, NC, 1981: 110-115. 45. Miller JP, Wette R, Parks RP. Type I Error Rates for the Unequal Variance T Test. Proceedings of the 6th Annual SUGI Conference, SAS Institute, Raleigh, NC, 1981: 156-161. 46. Kleiger RE, Miller JP, Thanavaro S, Province MA, Martin TF, Oliver GC. Relationship between Clinical Features of Acute Myocardial Infarction and Ventricular Runs 2 Weeks to 1 Year After Infarction. Cardiology World 1981: 7:6. 47. Croughan JL, Miller JP, Koepke J, Whitman BY. Depression in Narcotic Addicts - A Prospective Study with a Five-Year Follow-Up. Comprehensive Psychiatry 1981: 22:428-433. 48. Croughan JL, Miller JP, Whitman BY, Schober JG. Alcoholism and Alcohol Dependence in Narcotic Addicts - A Prospective Study with a 5-Year Followup. J Drug & Alcohol Abuse, 1981: 8:85-94. 49. Krone RJ, Miller JP, Kleiger RE, Clark KW, Oliver GC. The Effectiveness of Antiarrhythmic Agents on Early Cycle PVCs. Circulation 1981: 63:664-669. 50. Anderson B, Miller JP, Auslander W, Santiago J. Family Characteristics of Diabetic Adolescents. Diabetic Care 1981: 4:586-594. 51. Miller JP, Wette R. Type I Error Rates for the Behrens-Fisher Problem. Proceedings of the 1981 Statistical Computing Section of ASA, 1981: 160-164. 52. Croughan JL, Miller JP, Matar A, Whitman BY. Psychiatric Diagnosis and Prediction of Drug and Alcohol Dependence. J Clin Psychiatry 1982: 43:353-356. 53. Province MA, McCrate MM, Miller JP. PROC COMPARE and HEADER for Efficient Database Management in SAS. Proceedings of the 7th Annual SUGI Conference, 1982: 857-859. 54. Province MA, Miller JP, Wette R. PROC TETCORR: Correlations Between Categorical and Continuous Variables. Proceedings of the 7th Annual SUGI Conference, 1982: 672-675. 55. Croughan JL, Miller JP, Wangelin D, Whitman BY. Psychiatric Illness in Male and Female Narcotic Addicts. J Clin Psychiatry 1982: 43:223-228. 56. Croughan JL, Miller JP, Whitman BY, Lavazzi CM. Methods for Recording Lifetime History of Substance Abuse. Int J Addiction 1982: 17:1065-1078. 57. Clark KW, Geltman EM, Miller JP, Madden KA, Thomas LT, Jr, Jaffe AS, Gold HK, Raabe DS, Stone PH, Rude RE, Hartwell TD, MILIS Cooperating Investigators. Reproducibility of Dysrhythmia Findings by a Centralized Laboratory within a Major Multicenter Trial. Proceedings of the 1982 Computers in Cardiology, 1982: 55-60. 58. Thanavaro S, Kleiger RE, Province MA, Hubert J, Miller JP, Krone RJ, Oliver GC. Effect of Infarct Location on the In-Hospital Prognosis of Patients with First Transmural Myocardial Infarction. Circulation 1982: 66:742- 747. 5 59. Whitman BY, Croughan JL, Miller JP, McKay J. Nonpsychiatric Predictors of Narcotic Dependence: A Prospective Study with a 5-Year Followup. Int J Addiction 1982: 17:473-491. 60. Bach PR, the CIDD Group. Determination of Nifedipine in Serum or Plasma by Reversed-Phase Liquid Chromatography. Clin Chem 1983: 29:1344-1348. 61. Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Rowold E, Hoffman P, Faller A, Kilo C, Miller JP, Williamson JR. Muscle Capillary Basement Membrane in Identical Twins Discordant for Insulin-Dependent Diabetes. Diabetes 1983: 32:557-560. 62. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: II. Determination of the "Power" of Therapeutic Trials Based on the Natural History. Muscle & Nerve 1983: 6:91-103. 63. Ganda OP, Williamson JR, Soeldner JS, Gleason RE, Kilo C, Kaldany A, Miller JP, Garovoy MR, Carpenter CB. Muscle Capillary Basement Membrane Width and Its Relationship to Diabetes Mellitus in Monozygotic Twins. Diabetes 1983: 32:549-556. 64. Krone RJ, Friedman E, Thanavaro S, Miller JP, Kleiger RE, Oliver GC. Long-term Prognosis of Patients with First Q-Wave (Transmural) or Non-Q-Wave (Nontransmural) Myocardial Infarction: Analysis of 593 Patients. Am J Cardiology 1983: 52:234-239. 65. Lewis CE, Croughan JL, Whitman BY, Miller JP. The Association of Alcoholism and Antisocial Personality in a Narcotic Dependent Population: The Lexington Addicts. Psy Res 1983: 10:31-46. 66. Thanavaro S, Kleiger RE, Miller JP, Province MA, Friedman E, Oliver GC. Coupling Interval and Types of Ventricular Ectopic Activity Association with Ventricular Runs. Am Heart J 1983: 106:484-491. 67. Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE. Neuroendocrine Responses to Glucose Ingestion in Man: Specificity, Temporal Relationships and Quantitative Aspects. J Clin Invest 1983: 72:270-277. 68. Miller JP. Letter to the Editor Re: Adverse Reactions to Contrast Material. Radiology 1983: 149:325. 69. The Multicenter Postinfarction Research Group. Risk Stratification and Survival after Myocardial Infarction. New England J Medicine 1983: 309:331-336. 70. Florence JM, Pandya S, King WM, Robison J, Signore L, Wentzell M, Province M, CIDD Group. Clinical Investigation in Duchenne Dystrophy: 3. Standardization and Reliability of Evaluation Procedures. Physical Therapy 1984: 64:41-45. 71. Rosen SG, Clutter WE, Shah SD, Miller JP, Bier DM, Cryer PE. Direct Alpha-adrenergic Stimulation of Hepatic Glucose Production in Postabsorptive Man. Am J Psych 1983: 245:616-626. 72. Thomas LJ, Miller JP. Long-Term Ambulatory ECG Recording in the Determination of Antidysrhythmic Drug Efficacy. Clinical Pharmacology of Antiarrhythmic Therapy, BR Lucchesi, JV Dingell, RP Schwarz, Jr. (eds), Raven Press, New York, 1984. 73. Hopper S, Miller JP, Birge C, Swift J. A Randomized Study of the Impact of Home Health Aides on Diabetic Control and Utilization Patterns. Am J Pub Health 1984: 74:600-602. 74. Brooke MH, the CIDD Group. Therapeutic Trials in Duchenne Muscular Dystrophy. The Scientific Difference between "Didn't" and "Doesn't". Ital J Neurol Sci, Suppl 1984: 3:127-131. 75. Krone RJ, Miller JP, Province MA, Kleiger RE, Thanavaro S, Oliver GC. Prognosis in Transmural and Nontransmural Myocardial Infarction. Primary Cardiology 1984: 10:8-22. 76. Bigger JT, Fleiss JL, Kleiger RE, Miller JP, Rolnitzky LM, Multicenter Postinfarction Research Group. The Relationships Among Ventricular Arrhythmias, Left Ventricular Dysfunction, and Mortality in the 2 Years After Myocardial Infarction. Circulation 1984: 69:25025-8. 77. Mendell JR, Griggs RC, Moxley RT, Fenichel GM, Brooke MH, Miller JP, Province MS, Dodson WE, the CIDD Group. Clinical Investigation in Duchenne Muscular Dystrophy: IV. Double-Blind Controlled Trial of Leucine. Muscle & Nerve 1984: 7:535-541. 78. Miller JP. Use of Diagnostic Registries and DataBases. Muscle & Nerve, MDA Colloquium, 1985. 79. Krone RJ, Gillespie JA, Weld FM, Miller JP, Moss AJ, Multicenter Postinfarction Research Group. Low- Level Exercise Testing after Myocardial Infarction: Usefulness in Enhancing Clinical Risk Stratification. Circulation 1985: 71:80-89. 80. Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province MA, Moxley RT, III, Huntzinger D, Vaughn A, Cohen M, Conneally PM, Bach P, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: V. Use of Creatine Kinase and Pyruvate Kinase in Carrier Detection. Muscle & Nerve 1985: 8:60-67. 81. Gonen B, White N, Schonfeld G, Skor D, Miller JP, Santiago J. Plasma Levels of Apoprotein B in Patients with Diabetes Mellitus: The Effect of Glycemic Control. Metabolism 1985: 34:675-679. 82. Storch GA, Perrillo RP, Miller JP, Benz B, Kahn RH. Prevalence of Hepatitis B Antibodies in Personnel at a Children's Hospital. Pediatrics 1985: 76:29-35. 83. Doherty RA, Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Conneally PM. Use of Genetic-Linkage Combined with Serum Creatine-Kinase and Pyruvate-Kinase for Carrier Detection in Duchenne Dystrophy. Pediatric Res 1985: 19:4. 84. Brooke MH, Florence JM, Heller SL, Kaiser KK, Phillips D, Gruber A, Babcock D, Miller JP. Controlled Trial of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis. Neurology 1986: 36:146-151. 6 85. Rogers DG, White NH, Santiago JV, Miller JP, Weldon VV, Kilo C, Williamson JR. Glycemic Control and Bone Age are Independently Associated with Muscle Capillary Basement Membrane Width in Diabetic Children after Puberty. Diabetes Care 1986: 9:453-459. 86. Madsen KS, Miller JP, Province MA, the CIDD Group. The Use of an Extended Baseline Period in the Evaluation of Treatment in a Longitudinal Duchenne Muscular Dystrophy Trial. Statistics in Medicine 1986: 5:231-241. 87. Moxley RT, III, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: VI. Double-Blind Controlled Trial of Nifedipine. Muscle & Nerve, 1987: 10:22-33. 88. Wetzel RD, Reich T, Murphy GE, Province MA, Miller JP. The Changing Relationship Between Age and Suicide Rates: Cohort Effect, Period Effect or Both? Psychiatric Developments 1987: 3:179-218. 89. Kleiger RE, Miller JP, Bigger JT, Jr, Moss AJ, Multicenter Post-Infarction Research Group. Decreased Heart Rate Variability and Its Association with Increased Mortality After Acute Myocardial Infarction. Am J Cardiology 1987: 59:256-262. 90. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L, King W, Robison J, Head RA, Province M, Seyfried W, Mandel S. Clinical Investigation of Duchenne Dystrophy: Interesting Results in a Trial of Prednisone. Arch Neurology 1987: 44:812-17. 91. Mendell JR, Province MA, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, Kaiser KK, King W, Robison J, Signore L, Pandya S, Florence JM, Seyfried W, Mandel S. Clinical Investigation of Duchenne Muscular Dystrophy: A Methodology for Therapeutic Trials Based on Natural History Controls. Arch Neurology 1987: 44:808-812. 92. Krone RJ, Miller JP, Gillespie JA, Weld FM, Multicenter Post-Infarction Research Group. Usefulness of Low Level Exercise Testing Early After Acute Myocardial Infarction in Patients Taking Beta Blocking Agents. Am J Cardiology 1987: 60:23-27. 93. Miller JP, Parks RP. What Good is the SAS System for Personal Computers? Proceedings of the 12th Ann SUGI Conference, SAS Institute, Cary NC, 1987: 827-834. 94. Hyser CL, Province MA, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Polakowaska R, Doherty RA, Quirk S, CIDD Group. Genetic Heterogeneity in Duchenne Dystrophy. Ann Neurology 1987: 22:553-555. 95. Mandel SA, Miller JP. A Data Base Interrogation System with the SAS System for Personal Computers. Proceedings of the 13th Annual SUGI Conference, SAS Institute, Cary NC, 1988: 681-685. 96. Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J, Wittels IG, Berg L. Reliability of the Washington University Clinical Dementia Rating. Arch Neurology 1988: 45:31-32. 97. Berg L, Miller JP, Storandt M, Duchek J, Morris J, Rubin E, Burke W, Coben L. Mild Senile Dementia of the Alzheimer Type: 2, Longitudinal Assessment. Ann Neurology 1988: 23:477-484. 98. Krone RJ, Gillespie JA, Weld FM, Miller JP. Low-Level Exercise Testing in Patients taking Beta Blocking Agents. Card Board Rev 1988: 5:165-176. 99. Faber-Langendoen K, Morris J, Knesevich J, LaBarge E, Miller JP, Berg L. Aphasia in Senile Dementia of the Alzheimer Type. Ann Neurology 1988: 23:365-70. 100. Bigger JT, Jr., Kleiger RE, Fleiss JL, Rolnitzky LM, Steinman RC, Miller JP, Multicenter Post-Infarction Research Group. Components of Heart Rate Variability Measured During Healing of Acute Myocardial Infarction. Am J Cardiology 1988: 61:208-215. 101. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT, Park JH, Province MA, Florence J, Kaiser KK, King WM, Pandya S, Robison JD, Signore L. Clinical Investigation in Duchenne Muscular Dystrophy: VII. Double Blind Controlled Trial of Penicillamine and Vitamin E. Muscle & Nerve 1988: 11:1164- 1168 102. The Multicenter Diltiazem Postinfarction Trial Research Group. The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction. New England J Medicine 1988: 319:385-392. 103. Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr B, Moxley R. Randomized Controlled Trial of Testosterone in Myotonic Dystrophy. Neurology 1989: 39:219-222. 104. Krone RJ, Dwyer EM, Greenberg H, Miller JP, Gillespie JA, the Multicenter Post-Infarction Research Group. Risk Stratification in Patients with First Non-Q-Wave Infarction, Limited Value of the Early Low Level Exercise Test after Uncomplicated Infarcts. J Am College of Cardiology 1989: 14:31-37. 105. Brooke MH, Fenichel GM, Griggs, RC, Mendell JR, Moxley R, Miller JP, Gilder BF, Florence J, Kaiser KK, King WM, Pandya S, Robison J, Signore L, Mandel S, Arfken C. Duchenne Muscular Dystrophy: Patterns of Clinical Progression and Effects of Supportive Therapy. Neurology 1989: 39:475-481. 106. Miller JP. Statistical Considerations for Quantitative Techniques in Clinical Neurology. Quantification of Neurologic Deficit, Theodore Munsat, (ed), Butterworths, Stoneham MA, 1989: 69-84. 107. Mendell JR, Moxley RT, Griggs, RC, Brooke MW, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, Schierbecker J, Robison J, Kaiser K, Mandel S, Arfken C, Gilder B. Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy. New England J Medicine, 1989: 320:1592- 1597. 7 108. Miller JP. The SAS System on the UNIX Operating Systems and Derivatives: The Missing Link. Proceedings of the 1989 SAS User's Group International 1989: 1623-1627. 109. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Mandel S, Florence J, Schierbecker J, Kaiser KK, King W, Pandya S, Robison J, Signore L. Randomized, Double-Blind Trial of Mazindol in Duchenne Dystrophy, Muscle & Nerve 1990: 13:1169-1173. 110. Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LM, Therneau TM. Nonfatal Myocardial Infarction Is, by Itself, an Inappropriate Endpoint in Clinical Trials in Cardiology. Circulation 1990: 81:684-685. 111. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing Family Sharing of Diabetes Responsibilities. J Ped Psych 1990: 15:477-492. 112. Berg L, Smith DS, Morris JC, Miller JP, Rubin EH, Storandt M, Coben LA. Mild Senile Dementia of the Alzheimer Type: 3. Longitudinal and Cross-Sectional Assessment, Annals of Neurology 1990: 28:648-652. 113. Kleiger RE, Miller JP, Krone RJ, Bigger JT, the Multi-Center Post-Infarction Research Group. The Independence of Cycle Length Variability and Exercise Testing on Predicting Mortality of Patients Surviving Myocardial Infarction. Am J Cardiology, 1990: 65:408-411. 114. Miller, JP. Statistical Considerations in Clinical Trials. Muscle & Nerve 1990: 13:S43-S44. 115. Wozniak DF, Olney JW, Kettinger L, III, Price M, Miller JP. Behavioral effects of MK-801 administration in the Rat, Psych Pharm 1990: 101:47-56. 116. Clifford DB, Jacoby RG, Miller JP, Seyfried WR, Glicksman M. Neuropsychometric Performance of Asymptomatic Human Immunodeficiency Virus Patients. AIDS 1990: 4:767-774. 117. Kissel JT, Burrow KL, Rammohan KW, Mendell JR, CIDD Study Group. Mononuclear Cell Analysis of Muscle Biopsies in Prednisone-Treated and Untreated Duchenne Muscular Dystrophy. Neurology 1991: 41:667-672. 118. Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AHM, Mendell JR, CIDD Study Group. Dystrophin Expression and Somatic Reversion in Prednisone-Treated and Untreated Duchenne Dystrophy. Neurology 1991: 41:661-666. 119. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP and the CIDD Group. Prednisone in Duchenne Dystrophy: A Randomized, Controlled Trial Defining the Time Course and Dose Response, Archives of Neurology 1991: 48:383-388. 120. Lach HW, Arfken CL, Reed AT, Miller JP, Birge SJ, Peck WA. Falls in the Elderly: Reliability of a Classification System. J Am Geriatrics Society 1991: 39:197-202. 121. Porter FL, Miller JP, Marshall RE, Cole FS. A Controlled Clinical Trial of Local Anesthesia for Lumbar Punctures in Newborn Infants. Pediatrics, 1991:88:663-669. PMID 1896268 122. Burke WJ, O'Malley KL, Chung HD, Harmon SK, Miller JP, Berg L. Effect of Pre- and Postmortem Variables on Specific mRNA Levels in Human Brain. Molecular Brain Research 1991: 11:37-41. 123. Kahn MG, Abrams CA, Orland MJ, Beard JC, Cousins SB, Miller JP, Santiago JV. Intelligent Computer- based Interpretation and Graphical Presentation of Self-monitored Blood Glucose and Insulin Data. Diabetes, Nutrition and Metabolism 1991: 4:99-107. 124. Perry HM, Masironi R, Parr R, Miller JP. Concentration of Trace Metals (Cd, Zn, Se, Cu, Cr, and Fe) in Organs (Heart, Kidney, and Liver) of Subjects with Myocardial Infarction or Hypertension: WHO/IAEA Myocardial Infarction and Hypertension Autopsy Study. J Trace Elements in Experimental Medicine 1991: 4:109-128. 125. Cumming RG, Miller JP, Kelsey JL, Davis P, Arfken CL, Birge SJ, Peck WA. Medications and Multiple Falls in the Elderly: The St. Louis OASIS Study. Age & Aging 1991: 20:455-461. 126. Fenichel GM, Florence MJ, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W, Signore L, Pandya S, Schierbecker J, Wilson B. Long-Term Benefit from Prednisone Therapy in Duchenne Muscular Dystrophy. Neurology 1991: 41:1847-1877. 127. Fenichel GM, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, Pandya S, Florence J, Schierbecker J, Wilson B. A Comparison of Daily and Alternate-Day Prednisone Therapy in the Treatment of Duchenne Muscular Dystrophy. Archives of Neurology 1991: 48:575- 579. 128. Wozniak DF, Stewart GR, Miller JP, Olney JW. Age-Related Sensitivity to Kainate Neurotoxicity. Experimental Neurology 1991: 114:250-253. 129. Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ, Miller JP, Abrams JC, Goldstein R, Moss AJ, and the Multicenter Diltiazem Post-Infarction Trial Research Group. Electrocardiographic Subset Analysis of Diltiazem Administration on Long-Term Outcome after Acute Myocardial Infarction. Am J Cardiology 1991: 67:335-342. 130. Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G. Mild Senile Dementia of the Alzheimer Type: 4. Evaluation of Intervention. Annals of Neurology 1992: 31:242-249.

8 131. Florence J, Pandya S, King W, Robison J, Baty J, Miller JP, Schierbecker J, Signore L. Intrarater Reliability of the Manual Muscle Test (Medical Research Council Scale) in Duchenne's Muscular Dystrophy. Physical Therapy 1992: 72:115-122, 124-16 (author response). 132. Erdman HP, Klein MH, Greist JH, Skate SS, Husted JJ, Robins LN, Helzer JE, Goldring E, Hamburger M, Miller JP. A Comparison of Two Computer-Administered Versions of the NIMH Diagnostic Interview Schedule. J Psych Research 1992: 26:85-95. 133. Perry HM, Miller JP. Difficulties in Diagnosing Hypertension: Implications and Solutions. J Hypertension 1992: 10:887-896. 134. Buller RS, Bailey TC, Ettinger NA, Keener M, Langlois T, Miller JP, Storch GA. Use of a Modified Shell Vial Technique to Quantitate Cytomegalovirus Viremia in a Population of Solid-Organ Transplant Recipients. J Clin Microbiology 1992: 30:2620-2624. 135. Pinheiro JMB, Porter F, Miller JP, Cole FS, Marshall RE. Pediatrics 1992: 89(5): 976. PMID 1579415 136. Cumming RG, Miller JP, Birge SJ, Davis P. Medications, Fallers and Non-fallers (author response to Letter to the Editor) Age & Aging 1992: 21:226-227. 137. Rubin EH, Storandt M, Miller JP, Grant EA, Kinscherf DA, Morris JC, Berg L. Influence of Age on Clinical and Psychometric Assessment of Subjects with Very Mild or Mild Dementia of the Alzheimer Type. Archives of Neurology 1993: 50:380-383. 138. Berg L, McKeel DW, Jr., Miller JP, Baty J. Neuropathologic Indexes of Alzheimer's Disease in Demented and Nondemented People Aged Eighty Years and Over. Archives of Neurology 1993: 50:349-358. 139. McKeel DW, Ball MJ, Price JL, Smith DS, Miller JP, Berg L, Morris JC. Interlaboratory Histopathologic Assessment of Alzheimer Neuropathology: Different Methodologies Yield Comparable Diagnostic Results. Alzheimer Disease and Associated Disorders 1993: 7:136-151. 140. Ory MG, Schechtman KB, Miller JP, Hadley EC, Fiatarone MA, Province MA, Arfken CL, Morgan D, Weiss S, Kaplan M, and the FICSIT Group. Frailty and Injuries in Later Life: The FICSIT Trials. J Am Geriatrics Society 1993: 41:283-296. 141. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J, King W, Signore L, Schierbecker J, Florence J, Matheson-Burden N, Wilson B. Duchenne Dystrophy: Randomized, Controlled Trial of Prednisone (18 Months) and Azathioprine (12 Months). Neurology 1993: 43:520-527. 142. Buchner DM, Hornbrook MC, Kutner NG, Tinetti ME, Ory MG, Mulrow CD, Schechtman KB, Gerety MB, Fiatarone MA, Wolf SL, Rossiter J, Arfken C, Kanten K, Lipsitz LA, Sattin RW, DeNino LA, and the FICSIT Group. Development of the Common DataBase for the FICSIT Trials. J Am Geriatrics Society 1993: 41:297- 308. 143. Ory M, Schechtman K, Miller JP, Hadley E, Fiatarone M, Province M, Arfken C, Morgan D, Weiss S and the FICIST Group. Frailty and Injuries in Later Life: the FICSIT Trials. J Am Geriatrics Society 1993: 41:283-296. 144. Arens M, Joseph T, Nag S, Miller JP, Powderly WG, Ratner L. Alterations in Spliced and Unspliced HIV-1- Specific RNA Detection in Peripheral Blood Mononuclear Cells of Individuals with Varying CD4-Positive Lymphocyte Counts. AIDS Research and Human Retroviruses 1993: 9:1257-1263. 145. Kutner N, Schechtman K, Ory M, Baker D and the FICSIT Group. Older Adults' Perceptions of their Health and Functioning in Relation to Sleep Disturbance, Falling and Urinary Incontinence. J Am Geriatrics Society 1994: 42:757-762. 146. Arfken CL, Lach HW, Birge SJ, Miller JP, The Prevalence and Correlates of Fear of Falling in Community- Dwelling Elderly Persons. Am J Pub Health 1994: 84:565-570. 147. Miller JP, Perry HM, Rossiter JE, Baty JD, Carmody SE, Sambhi MP. Regional Differences in Mortality During 15 Year Follow-up of 11,936 Hypertensive Veterans. Hypertension 1994: 23:431-438. 148. Gates GA, Karzon RK, Garcia P, Peterein J, Storandt M, Morris JC, Miller JP. Auditory Dysfunction in Aging and Senile Dementia of the Alzheimer's Type. Archives of Neurology 1995: 52:626-634. 149. Perry HM, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE. Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients. Hypertension 1995: 25:587-594. 150. Arfken CL, Lach H, McGee S, Birge SJ, Miller JP. Visual Acuity, Visual Disabilities and Falling in the Elderly. J of Aging & Health 1994: 6:38-50. 151. Cress ME, Schechtman K, Mulrow C, Gerety M, Fiatarone M, Buchner D, Martin M and the FICSIT Study Group. Relationship between physical performance and Self-Perceived Physical Function. J Am Geriatrics Society 1995: 43:93-101. 152. Fix AS, Wozniak DF, Truex LL, McEwen M, Miller JP, Olney JW. Quantitative Analysis of Factors Influencing Neuronal Necrosis Induced by MK-801 in the Rat Posterior Cingulate/Retrosplenial Cortex. Brain Research 1995: 696:194-204. 153. Province M, Miller JP, Tinetti M, Hadley E, Wolf S, Mulrow C, Lipsitz L, Sattin R, Ory M, Hornbrook M. The Effects of Exercise on Falls in the Frail Elderly: A Pre-Planned Meta-Analysis of the FICSIT Trials. J Amer Medical Assoc 1995: 273:1341-1347.

9 154. Rossiter-Fornoff JE, Wolf SL, Wolfson LI, Buchner DM and the FICSIT Group. A Cross-sectional Validation Study of the FICSIT Common Data Base Static Balance Measures. J of Gerontology: Medical Sciences 50:M291-M297, 1995. 155. Porter FL, Malhotra KM, Wolf CM, Smith MC, Miller JP, Morris JC. Dementia and Response to Pain in the Elderly. Pain, 1996: 68:413-421. PMID 9121831 156. Miller DK, Carter ME, Sigmund RH, Smith JQ, Miller JP, Bentley JA, McDonald K, Coe RM, Morley JE. Nutritional Risk in Inner-City-Dwelling Older Black Americans, J Am Geriatrics Society, 1996: 44:959-62. 157. Miller JP. Confounding and Comorbidity in Sarcopenia Research, Muscle & Nerve, Supplement 1997: 5:S35-S38. 158. Porter FL, Wolf CM, Gold J, Lotsoff D, Miller JP. Pain and Pain Management in Newborn Infants: A Survey of Physicians and Nurses. Pediatrics, 1997: 100:626-632. PMID 9310516 159. Schechtman KB, Kutner NG, Wallace RB, Buchner DM, Ory MG and the FICSIT Group. Gender, Self- Reported Depressive Symptoms, and Sleep Disturbance Among Older Community-Dwelling Persons. J. Psychosomatic Res 1997: 43:513-527. 160. Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders A. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer's Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex and ApoE Genotype. Archives of Neurology, 1998: 55:326-335. 161. Kennedy RM, Porter FL, Miller JP, Jaffe D. Comparison of Fentanyl/Midazolam with Ketamine/Midazolam for Pediatric Orthopedic Emergencies. Pediatrics, 1998: 102:956-963. PMID 9755272 162. Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L. A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders. Archives of Neurology, 1998: 55:395-401. 163. Porter FL, Wolf CM, Miller JP. The Effect of Handling and Immobilization on the Response to Acute Pain in Newborn Infants. Pediatrics, 1998: 102:1383-1389. PMID 9832573 164. Miller DK, Morrison MJ, Blair SD, Miller JP, Morley JE. Predilection for Frailty Remedial Strategies Among Black and White Seniors. Southern Medical J 1998: 91:375-380. 165. Neil JJ, Shiran SI, McKinstry RC, Schefft GL, Snyder AZ, Almi CR, Akbudak E, Aronovitz JA, Miller JP, Lee BCP, Conturo TE. Normal Brain in Human Newborns: Apparent Diffusion Coefficient and Diffusion Anisotropy Measured by Using Diffusion Tensor MR Imaging. Radiology 1998: 209:57-66. 166. Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI. Hippocampal Morphometry in Schizophrenia by High Dimensional Brain Mapping. Proc Natl Acad Sci 1998: 95:11406-411. 167. Porter FL, White D, Attaway N, Miller JP, Strunk RC. Absence of diurnal variability of airway reactivity and hypoxic ventilatory drive in adolescents with stable asthma. Journal of Allergy and Clinical Immunology, 1999: 103:804-809. PMID 10329813 168. Porter FL, Wolf CM, Miller JP. Procedural Pain in Newborn Infants: The Influence of Intensity and Development. Pediatrics 1999: 104:1-10. PMID 10390299 169. Schmitt FA, Miller JP, Kryscio RJ. Promoting Interactions with Basic Scientists and Clinicians: Summary of the Panel Session. Statistics in Medicine, 2000: 19:1463-1468. 170. Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwartz SW, Morris MM, Miller JP, Anderson CJ. Radiotherapy and Dosimetry of 64Cu-TETA-Tyr3-Octroetate in a Somatostatin Receptor-Positive Tumor- Bearing Rat Model. Clinical Cancer Research, 1999: 5:3608-3616. 171. Schmitz ML, Kennedy RM, Porter FL, Jaffe DM, Miller JP. Sedation in Emergency Situations. Pediatrics 199: 104:1167-8. PMID 10577147 172. Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyona H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB. A Double-Blind, Placebo-Controlled Study of Mycobacterium-Specific Human Immune Responses Induced by Intradermal Bacille Calmete-Guerin Vaccination. J Lab Clin Med, 1999: 134(3):244-252. 173. Gordon MO, Kass MA and the Ocular Hypertension Treatment Study (OHTS) Group. The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants. Archives of Ophthalmology 1999: 117:573-583. 174. Perry HM, Miller JP, Baty JD, Carmody SE, Sambhi MP. Pretreatment Blood Pressure as a Predictor of 21- Year Mortality, Am J Hypertension 2000: 13:724-733. 175. Trinkaus KM, Thompson PA, Miller JP. Using SAS/IntrNet Software to Support Distributed Data Entry, in Proceedings of the Twenty-Fith Annual SAS Users Group International Conference, SAS Institute (ed), 2000: 1212-1217. 176. Farber NB, Rubin EH, Newcomer JW, Kinscherf DA, Miller JP, Morris JC, Olney JW, McKeel DW. Increased Neocortical Neurofibrillary Tangle Density in Subjects with Alzheimer's Disease and Psychosis. Archives of General Psychiatry, 2000: 57:1165-1173. 177. Keltner JL, Johnso CA, Quigg JM, Cello KE, Mass MA, Gordon MA for the Ocular Hypertension Study Group. Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment Study (OHTS). Archives of Ophthalmology 2000: 118: 1187-1194. 10 178. Lipfert FW, Perry HM, Jr., Miller JP, Baty JD, Wyzga RE, Carmody SE. The Washington University-EPRI Veterans' Cohort Mortality Study: Preliminary Results. Inhalation Toxicology 2000: 12:41-73. 179. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI. Early DAT is distinguished from Aging by High Dimensional Mapping of the Hippocampus Neurology, 2000: 55:1636- 1643. 180. Luhmann JD, Kennedy RM, Porter FL, Miller JP, Jaffe, DM. A Randomized Clinical Trial of Continuous Flow Nitrous Oxide and Midazolam for Sedation of Young Children during Laceration Repair. Annals of Emergency Medicine, 2001: 37:20-27. PMMID 11145766 181. Morris JC, Storandt M, Miller JP, McKeel, Jr DW, Price JP, Rubin EH, Berg L. Mild Cognitive Impairment Represents Early-Stage Alzheimer's Disease. Archives of Nerology, 2001: 58:397-405. 182. Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT. Clinicopathologic Assessment and Grading of Embolized Meningiomas: A Correlative Study of 64 Patients, Cancer 2001: 92:701-711. 183. Lin SP, Song SK, Miller JP, Ackerman JJH, Neil JJ. A direct, longitudinal comparison of 1H and 23Na MRI following transient focal cerebral ischemia. Stroke 2001: 32:925-932. 184. Binder EF, Miller JP, Ball LJ. Development of a Test of Physical Performance for the Nursing Home Setting (NHPPT). Gerontologist 2001: 41:671-679. 185. Thompson PA, Littlewood S, Adelman AJ, Miller JP. The Web Data Entry System: Methods for Web Development and SAS Data Management, Proceedings of the SAS Users Group International, April, 2002. 186. Trinkaus KM, Miller JP. Principles of Clinical Trials. In The Washington Manual of Oncology, Govindan R, Arquette M (eds). Lippincott, Philadelphia, 2002, pp. 1-10. 187. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: A Randomized Trial Determines that Topic Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle Glaucoma, Arch Opthalmol 2002: 120:701-713. 188. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Kass MA for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Baseline Factors that Predict the Onset of Primary Open-Angle Glaucoma. Arch Opthalmol 2002: 120:714-720. 189. Feuer WJ, Parrish RK, Schiffman JC, Anderson DR, Budenz DL, Wells MC, Hess DJ, Kass MA, Gordon MO and the Ocular Hypertension Treatment Study Group. The Ocular Hyppertension Treatment Study: Reproducibility of Cup/Disk Ratio Measurements Over Time at an Optic Disc Reading Center. Am J Opthalmol 2002: 133:19-28. 190. Csernansky JG, Miller JP, McKeel D, Morris JC. Relationships among Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer Type. Alzheimer Disease and Associated Disorders 2002: 16(3):144-149. 191. Ory MG, Lipman PD, Karlen PL, Gerety MB, Stevens VJ, Fiatarone Singh MA, Buchner DM, Schechtman KB, The FICSIT Group. Recruitment of Older Participants in Frailty/Injury Prevention Studies. Prevention Science 2002: 3(1):1-22. 192. Powlishta KK, Von Dras DD, Stanford A, Carr DB, Tsering C, Miller JP, Morris JC. The Clock Drawing Test is a Poor Screen for Very Mild Dementia. Neurology 2002: 59:898-903. 193. Storandt M, Grant EA, Miller JP, Morris JC. Rates of Progression in Mild Cognitive Impairment and Early Alzheimer’s Disease. Neurology 2002: 59:1034-1041. 194. Csernansky JG, Wang L, Jones D, Rastogi-Cruz D, Posener JA, Heydebrand G, Miller JP, Miller MI. Hippocampal Deformities in SchizophreniaCharacterized by High Dimensional Brain Mapping. Am J Psychiatry 2002: 159:2000–2006. 195. Lipfert FW, Perry HM Jr, Miller JP, Baty JD, Wyzga RE, Carmody SE: Air Pollution, Blood Pressure, and Their Long-Term Associations with Mortality. Inhalation Toxicology 2003: 15:493-512. 196. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O’Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP. Renal Structure in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney International 2003: 64:1035-1045. 197. Villareal DT, Grant E, Miller JP, Storandt M, Morris JC. Clinical Outcomes of Possible Versus Probable Alzheimer’s Disease. Neurology 2003: 61:661-667. 198. Winstein CJ, Miller JP, Blanton SB, Morris D, Uswatte G, Taub E, Nichols D, Wolf S. Methods for a Multi- site Randomized Trial to Investigate the Effect of Constraint-Induced Movement Therapy in Improving Upper Extremity Function among Adults Recovering from a Cerebrovascular Stroke. Neurorehabilitation and Neural Repair 2003: 17(3):137-152. 199. Miller JP, Schauer J, Baty JD, Littlewood S, Trinkaus K, Lill RM, Richards R. Managing Clinical Trials Data with a SAS-Based Web Portal, in Proceedings of the 2003 SAS Users Group International, April 2003 (also at http://www.biostat.wustl.edu/~phil/stuff/SCIP%20Paper.pdf).

11 200. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grangham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic Resonance Measurements of Renal Blood Flow as a Marker of Disease Severity in Autosomal Dominant Polycystic Kidney Disease. Kidney International 2003: 64:2214-2221. 201. Xiong C, Miller JP, Morris JC. Testing Correlation of Cognitive Decline at Adjacent Stages of Dementia. Journal of Alzheimer’s Disease 2003: 5:409-418. 202. Xiong C, Miller JP, Yan Y, Ji M. Effect of a Guarantee Time on Sample Size Determination for Testing the Ratio of Means from Two Lifetime Distributions. Journal of Biopharmaceutical Statistics 2004: 14(1):177-188. 203. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP. Health Related Quality of Life in Middle Aged African Americans. Journal of Gerontology 2004: 59B(2): S118-S123. PMID 15014099 204. Xiong C, Miller JP, Feng G, Yan Y, Morris JC. Testing for Increasing Hazard Rate for the Time of Progression associated with Alzheimer’s Disease. Discrete and Continuous Dynamical Systems-Series B 2004: 4(3):813-821. 205. Xiong C, McKeel DW, Miller JP, Morris JC. Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer's disease. Medical decision making: an international journal of the Society for Medical Decision Making, 2004: 24(6), 659-69. 206. Shah KR, Carr D, Roe CM, Miller JP, Coats M, Morris JC. Impaired Physical Performance and the Assessment of Dementia of the Alzheimer Type. Alzheimer Disease and Associated Disorders 2004: 18(3):112-119. 207. McKeel DW Jr, Price JL, Miller JP, Grant EA, Xiong C, Berg L, Morris JC. Neuropathologic Criteria for Diagnosing Alzheimer’s Disease in Persons with Pure Dementia of Alzheimer Type. Journal of Neuropathology and Experimental Neurology (JNEN) 2004: 63(10):1028-1037. 208. O'Neill WC, Robbin ML, Bae KT, Grantham JJ, Chapman AB, Guay-Woodford LM, Torres VE, King BF, Wetzel LH, Thompson PA, Miller JP. Sonographic Assessment of the Severity and Progression of Autosomal-Dominant Polycystic Kidney Disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis, 2005: 46(6): 1058-64. 209. Andresen EM, Malmstrom TK, Miller DK, Miller JP, Wolinsky FD. Retest Reliability of Self-Reported Function, Self-Care, and Disease History. Medical Care 2005: 43(1): 93-97. PMID 15626939 210. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP: Reproducibility of Physical Performance and Physiologic Assessments. Journal of Aging and Health 2005: 17(2):111-124. PMID 15750047 211. Fisher E, Musick J, Scott C, Miller JP, Gram R, Richardson V, Clark J, Pachalla V. Improving Clinic- and Neighborhood-Based Smoking Cessation Services within Federally Qualified Health Centers Serving Low- Income, Minority Neighborhoods. Nicotine & Tobacco Research 2005: 7(2):S1-S12. 212. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP. Further Evidence for the Importance of Sub-Clinical Functional Limitation and Subclinical Disability Assessment in Gerontology and Geriatrics. Journal of Gerontology: Social Sciences 2005: 60B(3): S146-S151. PMID 15860791 213. Malmstrom, TK, Wolinsky, FD, Andresen, EM, Miller, PM, Miller, DK. Cognitive Ability and Physical Performance in Middle Aged African Americans. J Am Geriatrics Society 2005: 53:997–1001. PMID 15935023 214. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, Miller JP, Storandt M, Morris JC. The AD8: A brief informant interview to detect dementia. Neurology 2005: 65:559-564. 215. Miller DK, Wolinsky FD, Malmstrom TK, Andresen EM, Miller JP. Inner City Middle Aged African Americans Have Excess Premature Frank and Subclinical Disability. Journal of Gerontology: Medical Sciences 2005: 60A:207-212. PMID15814864 216. Wilson M-MG, Miller DK, Andresen EM, Malmstrom TK, Miller JP, Wolinsky FD: Fear of Falling and Related Activity Restriction Among Middle Aged African Americans. J Gerontology: Medical Sciences 2005: 60A(3): 355-360. PMID 15860474 217. Wolf SW, Thompson PA, Taub E, Uswatte G, Miller JP, and the EXCITE Group. The EXCITE trial: Baseline attributes of the Wolf Motor Function Test in Patients with sub-acute stroke. Neurorehabilitation and Neural Repair 2005: 19(3):194-205. 218. Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC. Neuroanatomical Predictors of Response to Donepezil in Dementia Patients. Archives of Neurology 2005: 62:1718-1722. 219. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. Alzheimer disease and cancer. Neurology, 2005: 64(5), 895-898. 220. Lipfert FW, Wyzgab RE, Baty JD, Miller JP. Traffic density as a surrogate measure of environmental exposures in studies of air pollution health effects: Long-term mortality in a cohort of US veterans. Atmospheric Environment 2006: 40:154–169. 221. Miller DK, Andresen EM, Malmstrom TK, Miller JP, Wolinsky FD. Test-Retest Reliability of Subclinical Status for Functional Limitation and Disability. Journal of Gerontology: Social Sciences 2006: 61B(1): S52– S56. PMID 16399951 12 222. Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP, The CRISP Consortium. Predictors of renal function decline in autosomal dominant polycystic kidney disease: A comparison of methods. J Am Soc Nephrol, 2006: 17:854- 862. 223. Gao F, Thompson P, Xiong C, Miller JP. Analyzing Multivariate Longitudinal Data Using SAS. Proceedings of the SAS® Users Group International (SUGI 31) Conference, San Francisco, California, March, 2006. 224. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, for the CRISP Investigators. Volume Progression in Polycystic Kidney Disease. New England Journal of Medicine 2006: 354(20):2122-2130. 225. Xiong C, van Belle G, Miller JP, Morris JC. Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups. Statistics in Medicine, 2006: 25:1251-1273. 226. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal Course and Neuropathological Outcomes in Original vs Revised MCI and in PreMCI. Neurology, 2006: 67:467-473. 227. Andresen EM, Wolinsky FD, Miller JP, Wilson M-MG, Malmstrom TK, Miller DK. Cross-Sectional and Longitudinal Risk Factors for Falls, Fear of Falling, and Falls Efficacy in a Cohort of Middle Aged African Americans. Gerontologist, 2006: 46(2): 249-257. PMID 16581889 228. Kymes SM, Kass MA, Anderson D, Miller JP, Gordon MO for the OHTS Study Group. Management of patients with ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study Group (OHTS). American Journal of Ophthalmology, 2006: 141(6):997-1008. 229. Bae K, Zhu F, Chapman A, Torres V, Grantham J, Guay-Woodford L, Baumgarten D, King BF, Wetzel LH, Kenney P, Brummer M, Bennett W, Klahr S, Meyers C, Zhang X, Thompson P, Miller J. Magnetic Resonance Imaging (MRI) Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Clinical Journal of American Society of Nephrology, 2006: 1:64-69. 230. Wolf SL, Winstein C, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light K, Nichols-Larsen D. Effect of Constraint Induced Movement Therapy on Upper Extremity Function among Patients 3-9 Months Following Stroke: The EXCITE Randomized Clinical Trial. JAMA, 2006: 296(17):2095-2104. 231. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Miller DK. Neighborhood Conditions and Risk of Incident Lower-Body Functional Limitations among Middle-Aged African Americans. American Journal of Epidemiology, 2006: 163(5): 450-458. PMID 16421245 232. Wang L, Miller JP, Gado MH, McKeel DW, Miller MI, Rothermich M, Morris JC, Csernansky JG. Abnormalities of Hippocampal Surface Structure in Very Mild Dementia of the Alzheimer Type. NeuroImage, 2006: 30:52-60. 233. Harris PC, Bae KT, Rosetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang Q, Thompson PA, Zhu Fang, Miller JP, CRISP Consortium. Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol, 2006: 17:3013- 3019. 234. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP, Miller TR. Effect of Subclinical Status in Functional Limitation and Disability on Adverse Health Outcomes 3 Years Later. Journal of Gerontology: Medical Sciences. Journal of Gerontology: Medical Sciences, 2007: 62A(1) 101-106. PMID 17301046 235. Xiong C, Tang Y, van Belee G, Miller JP, Launer LJ, Bergmann KR, Morris JC. Assessing Statistical Applications in Publications on Alzheimer's Disease, Neuroepidemiology, 2007: 28:235-245. 236. Wolinsky FD, Miller TR, Malmstrom TK, Miller; JP, Schootman M, Andresen EM, Miller DK. Four-Year Lower Extremity Disability Trajectories Among African American Men and Women. J Gerontol: Medical Sciences, 2007: 62A(5):525-530. PMID 17522357 237. Rosetti S, Consugar M, Chapman A, Torres V, Guay-Woodford L, Grantham J, Bennett W, Meyers C, Walker D, Bae K, Zhang Q, Thompson P, Miller JP, Harris P, CRISP Consortium. Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol, 2007: 18:2143-2160. 238. Xiong C, van Belle G, Miller JP, Yan Y, Gao F, Yu K, Morris JC. A parametric comparison of diagnostic accuracy with three ordinal diagnostic groups. Biometrical Journal, 2007: 49(5):682-693. 239. Malmstrom TK, Andresen EM, Wolinsky FD, Miller JP, Stamps K, Miller DK. Mortality risk in older inner-city African Americans, Journal of the American Geriatrics Society, 2007: 55:1049-1055. PMID 17608878 240. Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group (Writing Committee:Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA). Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular Hypertension. Ophthalmology, 2007: 114:10-19. 241. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Miller DK. Neighborhood environment and the incidence of depressive symptoms among middle-aged African Americans. J Epidemiol Community Health, 2007: 61(6):527-532. 13 242. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Yan Y, Miller DK. The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans. American Journal of Epidemiology, 2007: 166(4):379-387. PMID 17496262 243. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Kraisthith A, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, and the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic Resonance Measurements of Renal Blood Flow and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology, Clin J Am Soc Nephrol, 2007: 2:112-120. 244. Roe CM, Xiong, Miller JP and Morris JC. Education and Alzheimer's Disease without Dementia. Support for the Cognitive Reserve Hypothesis Neurology, 2007: 68:223-228. 245. Wolf SL, Winstein CJ, Miller JP, Thompson PA, Taub E, Uswatte G, Morris D, Blanton S, Nichols-Larsen D, Clark PC. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol, 2008: 7:33–40 (published online December 11, 2007). 246. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Yan Y and Miller DK. Schootman et al. Respond to "Diabetes Causality in African Americans". Am J Epidemiology, 2007: 166(4), 391-392. 247. Xiong C, Tang Y, van Belle G, Miller JP, Launer LJ and Morris JC. Evaluating the Quality of Longitudinal statistical Applications in Original Publications on Alzheimer’s Disease. Methods in Neuroepidemiology, 2008: 30:112-119. 248. Wolinsky FD, Miller TR, Malmstrom TK, Miller JP, Schootman M, Andresen EM, Miller DK. Self-rated health: changes, trajectories, and their antecedents among African Americans. J Aging and Health, 2008: 20(2):143-158. PMID 18192487 249. Andreson EM, Malmstrom TK, Wolinsky FD, Schootman M, Miller JP, Miller DK. Rating Neighborhoods for Older Adult Health: Results from the African American Health Study. BMC Public Health, 2008: 8:35. PMID 18221546 250. Gao F, Trinkaus K, Miller JP. "Early Phase Clinical Trials: Phases I and II." Handbook of Statistics, Epidemiology and Medical Statistics. Ed. C R. Rao, J P. Miller, and D C. Rao. Vol. 27. Amsterdam: Elsevier B.V., 2008: 513-545. 251. Xiong C, Zhu K, Yu K, Miller JP. "Statistical Modeling in Biomedical Research: Longitudinal Data Analysis." Handbook of Statistics, Epidemiology and Medical Statistics. Ed. C R. Rao, J P. Miller, and D C. Rao. Vol. 27. Amsterdam: Elsevier B.V., 2008: 429-463. 252. Trinkaus K, Gao F, Miller JP. "Biostatistics 101 as Applied to Oncology." The Washington Manual of Oncology. Ed. Ramaswamy Govindan, Md. Philadelphia: Wolters Kluwer | Lippincott Williams & Wilkins, 2008: 61-67. 253. Miller DK, Wolinsky FD, Andresen EM, Malmstrom TK, Miller JP. Adverse outcomes and correlates of change in the Short Physical Performance Battery (SPPB) over 36 months in the African American Health project, J Gerontol: Medical Sciences, 2008: 63A(5), 487–494. 254. Roe C, Xiong C, Miller JP, Cairns N, Morris J. Interaction of Neuritic Plaques and Education Predicts Dementia. Alzheimer Disease & Associated Disorders, 2008: 22(2), 188-193. 255. The Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group (Writing Committee: Gordon MO, Kass MA, Torri V, Miglior S, Beiser J, Floriani I, Miller JP, Gao F, Adamsons I, Poli D). The Accuracy and Clinical Application of Predictive Models for Primary Open-Angle Glaucoma in Ocular Hypertensive Individuals. Ophthalmology, 2008: 115, 2030–2036. 256. Roe CM, Xiong C, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer disease, Archives of Neurology, 2008: 65(1), 108-111. 257. Lipfert FW, Wyzga RE, Baty JD, Miller JP. Vehicular traffic effects on survival within the Washington University-EPRI veterans cohort: new estimates and sensitivity studies, Inhalation Toxicology, 2008: 20(10), 949-60. 258. Malmstrom TK, Miller DK, Coats MA, Jackson P, Miller JP, Morris JC. Informant-Based Dementia Screening in a Population-Based Sample of African Americans. Alzheimer Disease & Associated Disorders, 2009: 23(2), 117-123. 259. Miller DK, Malmstrom TK, Andresen EM, Miller JP, Herning MM, Schootman M, Wolinsky FD. Development and Validation of a Short Portable Sarcopenia Measure in the African American Health Project. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 2009: 64A(3),388-394. PMID 19181712 260. Wolinsky FD, Malmstrom TK, Miller JP, Andresen EM, Schootman M, Miller DK. Antecedents of Global Decline in Health-Related Quality of Life Among Middle Aged African Americans. Journal of Gerontology: Social Sciences, 2009: 64(2), 290-295. PMID 19196694 261. Lipfert FW, Wyzga RE, Baty JD, J. Phillip Miller. Air pollution and survival within the Washington University- EPRI veterans cohort: risks based on modeled estimates of ambient levels of hazardous and criteria air pollutants. Journal of the Air & Waste Management Association, 2009: 59(4), 473-89.

14 262. Wolinsky FD, Andresen EM, Malmstrom TK, Schootman M, Miller JP, Miller DK. Three-Year Measured Weight Change in the African American Health Study. J Aging Health, 2009: 21, 231-243. PMID 19204381